Trajan announces acquisition of LEAP Technologies Inc.

Trajan announces acquisition of LEAP Technologies Inc.

April 05, 2016

Trajan Scientific and Medical “Trajan” today announced the acquisition of the business of LEAP Technologies (NC, USA).

Formed in 1989 Carrboro, NC in order to serve the automation needs of analytical laboratories (Chromatography and Mass Spectrometry related), LEAP delivers solutions in the fields of research and development, life science, pharmaceutical, polymer, food processing, forensic, and academia.

Bringing LEAP into the Trajan Group will complement the widening capability of Trajan, servicing their vision to make a positive impact on human wellbeing. It will improve science and laboratory workflows to ultimately bring testing of the sample closer to the source, while supporting improved efficiencies in the lab.

Chief Executive Officer of Trajan, Mr Stephen Tomisich, comments: “We are so pleased to welcome the LEAP team into the Trajan family. Trajan has a technology-rich development pipeline of disruptive sampling and sample preparation products speeding towards commercialization and LEAP provides the automation capability to allow adoption into laboratory workflows. We think it’s a partnership with huge potential!

Werner Martin, President of LEAP Technologies predicts: “The opportunity for LEAP to join Trajan will be a tremendous step forward to best apply new automation configurations for the fast evolving analytical chemistry laboratories worldwide. The synergies are multiple and can speed up the positive impact on human wellbeing by improving developments for laboratory automation and workflow.”

Mr Sal Iacono, LEAP Technologies CEO echoes this sentiment: “LEAP's team is very pleased about becoming part of the Trajan organization! In particular, the expanded opportunities to generate more disruptive, efficient and streamlined solutions such as LEAP's innovative HDX platform, for the life science, environmental and diagnostic markets is immensely exciting. We are eagerly looking forward to continuing and further expanding our relationships with superb technology partners such as CTC Analytics, Axel-Semrau and Gyger to name a few, in integrating their outstanding offerings with Trajan's many disruptive technologies to provide superior innovation to the marketplace.”

Download
Press Release [PDF]

Media Contact Information
Trajan Scientific and Medical
media@trajanscimed.com
+44 (0) 1244403100

More Information
www.leaptec.com




Also in News

Trajan acquires HDExaminer Software from California-based, Sierra Analytics Inc.
Trajan acquires HDExaminer Software from California-based, Sierra Analytics Inc.

February 15, 2023

Trajan Scientific and Medical announces the completion to acquire specialized software business, HDExaminer, from California-based, Sierra Analytics, Inc.

Read More

Trajan collaborates with Monash University for the development of HDX training centre
Trajan collaborates with Monash University for the development of HDX training centre

February 03, 2023

Trajan Scientific and Medical with Monash University would like to announce a collaboration for the development of an HDX training centre at Monash University's Proteomics and Metabolomics Facility (MPMF). This collaboration will provide the university with access to a Trajan HDX system and allow Trajan to provide HDX training to the proteomics community in the region.

Read More

Baker Institute research leads to simple tests for heart and diabetes disease
Baker Institute research leads to simple tests for heart and diabetes disease

January 13, 2023

Collaboration has been key to a global health innovation to counter cardiovascular disease. One of Australia’s leading research facilities, the Baker Heart and Diabetes Institute, had the technology to potentially revolutionise testing for heart disease and diabetes, using just a single drop of blood. All it lacked for this global breakthrough was commercial nous, developmental infrastructure and marketing know-how. On the other hand, Trajan Scientific and Medical, a Melbourne-based ASX biotech company, had the technology and expertise to take products to market.

Read More